340B Unscripted

Ep 9 | TPA Transition Tips and Tricks

In this episode, we have podcast guests Anna Bulochnik, and Chelsea Violette to discuss the challenging task of switching third-party administrators (TPAs). Great tips and recommendations on how to make the transition as smooth as possible. 

Ep 8 | Trulla - Modernizing Pharmacy Procurement

On this episode, Rob and Greg welcome a few new SpendMend colleagues - Curtis McEntire and Angela Whitney– to talk about Trulla, a state-of-the-art pharmacy procurement solution now offered by SpendMend. They’ll talk about the challenges of today’s pharmacy buyer, common untapped opportunities for drug savings, and how Trulla can bring your pharmacy procurement process into the future.

Ep 7 | Don’t be Haunted by a HRSA Audit!

It’s Halloween, and in this episode, Greg and Rob invite guests from the field to discuss “tricks and treats” from recent HRSA audit experiences! They’ll review strategies for gathering audit data, the coaching staff for the onsite visit, and what you need to consider when you eventually receive your final audit report. HRSA audits can be a “frightening” experience, but this conversation will give you lots of info to help you be ready! Also, the guys share updates on CMS OPPS payments for 340B hospitals.

Ep 6 | 340B NYT Article: Are You Next?

In this episode, Rob and Gren welcome William Mayhood to the Pod and get into the New York Times article on Bon Secours’ 340B program. We shift gears and get into what covered entities should be doing in preparation for a similar media article, or congressional inquiry, and bring back the 340B Impact Statement. You never know, your CE could be next!

Ep 5 | Weighing the Risk: Referral Capture vs. Continuum of Care

In this episode, Greg and Rob are joined by another SpendMend Pharmacy colleague – Riley Protz, who serves as Director of Optimization. They discuss the impact of referral capture opportunities on 340B Program participation and debate the risks of this strategy in comparison with other strategies, like the application of the “continuum of care” in the patient definition.

Ep 4 | Inflation Reduction Act’s 340B Impact

In Episode 4 of the 340B Unscripted podcast, Greg and Rob bring on Matt Parker, VP of Optimization and Growth at SpendMend AND the maestro behind the scenes of the podcast, to discuss the Inflation Reduction Act and how it impacts 340B. We discuss both the inflation penalty impact starting in 2023 and the negotiated Medicare pricing impact that starts in 2026.

Ep 3 | Future Outlook of 340B Contract Pharmacy Limitations

 In this episode, Greg and Rob are joined by SpendMend colleague Jacob Thompson to discuss the future outlook of the 340B Contract Pharmacy Limitations. They review past 340B/CMS litigation that ultimately ended at the Supreme Court. From that review, they predict the path and length of time these limitations are most likely in place. This is a very important topic as CEs navigate if they should submit data to 340B ESP.

Ep 2 | 2022 340B Coalition Summer Recap

In this episode, Greg and Rob are back from Washington, D.C., and are joined by SpendMend colleague Jennifer Hagen to recap highlights from the 2022 Summer 340B Coalition Conference. They dig into lessons learned from various sessions at the conference and chat about HRSA audit trends, operational challenges from recent manufacturer restrictions, as well as “big picture” considerations for 340B covered entities for the remainder of 2022. Also, stick around at the end of the episode to hear sound bytes from SpendMend staff, clients, and friends who gathered together at the conference!